annual cash & cash equivalents:
$4.89B-$1.61B(-24.76%)Summary
- As of today (August 31, 2025), ROIV annual cash & cash equivalents is $4.89 billion, with the most recent change of -$1.61 billion (-24.76%) on March 31, 2025.
- During the last 3 years, ROIV annual cash & cash equivalents has risen by +$2.82 billion (+136.85%).
- ROIV annual cash & cash equivalents is now -24.76% below its all-time high of $6.50 billion, reached on March 31, 2024.
Performance
ROIV Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$4.51B-$383.84M(-7.85%)Summary
- As of today (August 31, 2025), ROIV quarterly cash & cash equivalents is $4.51 billion, with the most recent change of -$383.84 million (-7.85%) on June 1, 2025.
- Over the past year, ROIV quarterly cash & cash equivalents has dropped by -$1.18 billion (-20.73%).
- ROIV quarterly cash & cash equivalents is now -32.51% below its all-time high of $6.68 billion, reached on December 31, 2023.
Performance
ROIV quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ROIV Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.8% | -20.7% |
| 3 y3 years | +136.8% | +131.5% |
| 5 y5 years | +123.7% | +111.3% |
ROIV Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.8% | +190.7% | -32.5% | +218.7% |
| 5 y | 5-year | -24.8% | +190.7% | -32.5% | +218.7% |
| alltime | all time | -24.8% | +475.5% | -32.5% | +218.7% |
ROIV Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $4.51B(-7.9%) |
| Mar 2025 | $4.89B(-24.8%) | $4.89B(-5.1%) |
| Dec 2024 | - | $5.15B(-4.5%) |
| Sep 2024 | - | $5.39B(-5.2%) |
| Jun 2024 | - | $5.68B(-12.5%) |
| Mar 2024 | $6.50B(+286.4%) | $6.50B(-2.7%) |
| Dec 2023 | - | $6.68B(+372.2%) |
| Sep 2023 | - | $1.41B(-1.8%) |
| Jun 2023 | - | $1.44B(-14.4%) |
| Mar 2023 | $1.68B | $1.68B(+9.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | - | $1.53B(-4.5%) |
| Sep 2022 | - | $1.60B(-17.6%) |
| Jun 2022 | - | $1.95B(-5.7%) |
| Mar 2022 | $2.06B(-3.2%) | $2.06B(-6.9%) |
| Dec 2021 | - | $2.22B(-11.3%) |
| Sep 2021 | - | $2.50B(+25.0%) |
| Jun 2021 | - | $2.00B(-6.3%) |
| Mar 2021 | $2.13B(-2.4%) | $2.13B(-2.4%) |
| Mar 2020 | $2.19B(+157.3%) | $2.19B |
| Mar 2019 | $849.55M | - |
FAQ
- What is Roivant Sciences Ltd. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Roivant Sciences Ltd.?
- What is Roivant Sciences Ltd. annual cash & cash equivalents year-on-year change?
- What is Roivant Sciences Ltd. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Roivant Sciences Ltd.?
- What is Roivant Sciences Ltd. quarterly cash & cash equivalents year-on-year change?
What is Roivant Sciences Ltd. annual cash & cash equivalents?
The current annual cash & cash equivalents of ROIV is $4.89B
What is the all time high annual cash & cash equivalents for Roivant Sciences Ltd.?
Roivant Sciences Ltd. all-time high annual cash & cash equivalents is $6.50B
What is Roivant Sciences Ltd. annual cash & cash equivalents year-on-year change?
Over the past year, ROIV annual cash & cash equivalents has changed by -$1.61B (-24.76%)
What is Roivant Sciences Ltd. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ROIV is $4.51B
What is the all time high quarterly cash & cash equivalents for Roivant Sciences Ltd.?
Roivant Sciences Ltd. all-time high quarterly cash & cash equivalents is $6.68B
What is Roivant Sciences Ltd. quarterly cash & cash equivalents year-on-year change?
Over the past year, ROIV quarterly cash & cash equivalents has changed by -$1.18B (-20.73%)